ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Recent studies using highly sensitive detection methods for the BCR-ABL1 transcript demonstrated that residual leukemic cells and CML LSCs can be detected even in patients who are in a molecular remission after TKI discontinuation (11, 12).